Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?

@article{Baselga2004CombiningTA,
  title={Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?},
  author={Jos{\'e} Baselga},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 5},
  pages={759-61}
}
  • José Baselga
  • Published 2004 in
    Journal of clinical oncology : official journal…

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Molecular therapy of head and neck cancer

Cancer and Metastasis Reviews • 2005
View 13 Excerpts
Highly Influenced

Antagonism between gefitinib and cisplatin in non-small cell lung cancer cells: why randomized trials failed?

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer • 2011

Similar Papers

Loading similar papers…